Beneficial effects of oligopeptides from marine salmon skin in a rat model of type 2 diabetes

Nutrition

Volumn 26, Issue 10, 2010, Pages 1014-1020

  Zhu, Cui Feng ^a,b   Peng, Hong Bing ^a   Liu, Gui Qin ^c   Zhang, Fan ^b   Li, Yong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c Hospital of Traditional Chinese Medicine of Futian District   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BOVINE SERUM ALBUMIN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GLUCOSE; GLUTATHIONE; INSULIN; MALONALDEHYDE; NATURAL PRODUCT; OLIGOPEPTIDE; SALMON SKIN EXTRACT; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; MARINE SPECIES; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONCORHYNCHUS; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SALMON; STREPTOZOCIN DIABETES;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD95; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; GLUTATHIONE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTERFERON-GAMMA; ISLETS OF LANGERHANS; MALE; MALONDIALDEHYDE; OLIGOPEPTIDES; OXIDATIVE STRESS; PROTEIN HYDROLYSATES; RATS; RATS, SPRAGUE-DAWLEY; SALMON; SERUM ALBUMIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

BOVINAE; RATTUS;

EID: 77957281648     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.01.011     Document Type: Article

References (28)

1. Xiang A.H., Peters R.K., Kjos S.L., Goico J., Ochoa C., Marroquin A., et al. Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell function. J Clin Endocrinol Metab 2004, 89:2846-2851.
2. International Diabetes Federation International Diabetes Federation. Diabetes Atlas 2003, Belgium, Brussels. 2nd ed.
3. Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
4. Gloyn A.L., McCarthy M.I. Genetics: how the UKPDS contributed to determining the genetic landscape of type 2 diabetes. Diabet Med 2008, 25(Suppl 2):35-40.
5. Zhang S., Liu H., Yu H., Cooper G.J. Fas-associated death receptor signaling evoked by human amylin in islet beta-cells. Diabetes 2008, 57:348-356.
6. Frisard M., Ravussin E. Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process. Endocrine 2006, 29:27-32.
7. Gungor N., Bacha F., Saad R., Janosky J., Arslanian S. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?. Diabetes Care 2005, 28:638-644.
8. Robertson R.P., Harmon J., Tran P.O., Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004, 53(Suppl 1):119-124.
9. Cnop M., Welsh N., Jonas J.C., Jörns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005, 54(Suppl 2):S97-S107.
10. Kagi D., Odermatt B., Seiler P., Zinkernagel R.M., Mak T.W., Hengartner H. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 1997, 186:989-997.
11. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway C.A., et al. The role of Fas in autoimmune diabetes. Cell 1997, 89:17-24.
12. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
13. Ouellet V., Marois J., Weisnagel S.J., Jacques H. Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: a randomized controlled trial. Diabetes Care 2007, 30:2816-2821.
14. Liu G.Q., Zhu C.F., Li Y.F., Peng H.B., Lu H., Guo S.C., et al. Effect of marine collagen peptide on the expression of overoxidation stress markers in rats with type 2 diabetes. J Clin Rehabil Tissue Eng Res 2008, 12:4469-4472.
15. DiPenta J.M., Green-Johnson J.M., Murphy R.J. Type 2 diabetes mellitus, resistance training, and innate immunity: is there a common link?. Appl Physiol Nutr Metab 2007, 32:1025-1035.
16. Rerup C.C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970, 22:485-518.
17. Reaven G.M., Ho H. Low dose streptozotocin induced diabetes in the spontaneously hypertensive rat. Metabolism 1991, 40:335-337.
18. Zhao Y.F., Feng D.D., Chen C. Contribution of adipocytederived factors to beta-cell dysfunction in diabetes. Int J Biochem Cell Biol 2006, 38:804-819.
19. Global Strategy on Diet, Physical Activity, and Health. WHO Report 2000, World Health Organization, WHO, Geneva.
20. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol 2000, 24:297-302.
21. Klompong V., Benjakul S., Kantachote D., Shahidi E. Antioxidative activity and functional properties of protein hydrolysate of yellow stripe trevally (Selaroides leptolepis) as influenced by the degree of hydrolysis and enzyme type. Food Chem 2007, 102:1317-1327.
22. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
23. Beutler E. Glutathione. Red blood cell metabolism: a manual of biochemical methods 1975, 112-114. Grune & Stratton, New York. E. Beutler (Ed.).
24. Vijaylingam S., Parthibhan S., Shanmugasundaram K.R., Mohan V. Abnormal antioxidant status in impaired glucose tolerance and noninsulin dependent diabetes mellitus. Diabetic Med 1996, 13:715-719.
25. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005, 52:313-320.
26. Yang R.Y., Zhang Z.F., Pei X.R., Han X.L., Wang J.B., Wang L.L., et al. Immunomodulatory effects of marine oligopeptide preparation from Chum Salmon (Oncorhynchus keta) in mice. Food Chem 2009, 113:464-470.
27. Togashi N., Ura N., Higashiura K., Murakami H., Shimamoto K. The contribution of skeletal muscle tumor necrosis factor-a to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000, 18:1605-1610.
28. Tsiavou A., Hatziagelaki E., Chaidaroglou A., Koniavitou K., Degiannis D., Raptis S.A. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 2005, 31:135-141.